SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-21-004256
Filing Date
2021-02-18
Accepted
2021-02-18 16:05:24
Documents
9
Period of Report
2021-02-18

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 31150
2 ex99-1.htm EX-99.1 284152
3 ex99-2.htm EX-99.2 127856
4 ex99-3.htm EX-99.3 19628
5 ex99-5.htm EX-99.5 21775
6 ex99-6.htm EX-99.6 17982
7 ex99-5_001.jpg GRAPHIC 10229
8 ex99-6_001.jpg GRAPHIC 10161
9 ex99-3_01.jpg GRAPHIC 5215
  Complete submission text file 0001493152-21-004256.txt   539357
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 21649510
SIC: 2834 Pharmaceutical Preparations